Baird Medical Investment Holdings Ltd
corporate_fare Company Profile
Baird Medical Investment Holdings Ltd (NASDAQ:BDMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 9 items for BDMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-03, rated 7/10. Across its 9 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for BDMD spans 6-K, 424B3, SCHEDULE 13D, 20-F/A.
Recent high-impact activity:
- Baird Medical Swings to Profitability: H1 2026 Revenue Up 25% to $9.9M, Net Income Positive
- Baird Medical Registers 34.4M Shares for Resale — 63.8% of Outstanding
- SPAC Sponsors Reveal 31.5% Baird Medical Stake Nearly Two Years After Deal Close
- Baird Medical Amends 20-F: $27.5M Loss, $42.5M in Overdue Receivables, but No Going Concern Doubt
- Baird Medical Establishes NYC Global HQ for U.S. Commercial Push
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for BDMD, detected from its recent SEC filings · based on capital-structure filings through 2026-08-18.
Universal Shelf Registration Filed · Significant Potential Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
BDMD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.